BOLT logo

Bolt Biotherapeutics, Inc. Common Stock


BOLT: Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.


Show BOLT Financials

Consumer Interest
SEC Filings

Recent trades of BOLT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by BOLT's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Thienoazepine immunoconjugates, and uses thereof May. 23, 2023
  • Patent Title: Immunoconjugates targeting her2 Aug. 02, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of BOLT in WallStreetBets Daily Discussion


Recent insights relating to BOLT

CNBC Recommendations

Recent picks made for BOLT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BOLT

Corporate Flights

Flights by private jets registered to BOLT